LysoPE(18:0)
|
Basic information |
| Metabolite name | LysoPE(18:0) |
 | N/A |
 |
N/A |
 |
N/A |
| Synonyms | NA |
| No. of studies | 7 |
|
Relationship between LysoPE(18:0) and depression (count: 7) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M061 | Type1 | depressed group vs. control group | Plasma | Human | Up |
| Study M096 | Type1 | CUMS group vs. control group | Hippocampus | Wistar rat | Up |
| Study M096 | Type2 | CUMS + paroxetine group vs. CUMS group | Hippocampus | Wistar rat | Down |
| Study M1086 | Type1 | CUMS group vs. control group | Liver | C57BL/6 mouse | Up |
| Study M125 | Type1 | depressed group vs. control group | Plasma | Human | Up |
| Study M540 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M883 | Type1 | MDD group vs. control group | Blood | Human | Up |
| Study M955 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6J mouse | Down |
| Study M955 | Type2 | CUMS + deoiled and dechlorogenic acid-enriched sunflower seeds group vs. CUMS group | Hippocampus | C57BL/6J mouse | Up |
| Study M955 | Type2 | CUMS + deoiled sunflower seeds group vs. CUMS group | Hippocampus | C57BL/6J mouse | Up |